New vaccines protect monkeys from Ebola and Marburg virus infections after a single shot. The live vaccines are built using a virus platform that should allow widespread protection in people, if the approach holds up in later safety and efficacy studies (pages 786–790).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Dynamic blood single-cell immune responses in patients with COVID-19
Signal Transduction and Targeted Therapy Open Access 06 March 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Feldmann, H., Jones, S., Klenk, H.-D. & Schnittler, H.-J. Nat. Rev. Immunol. 3, 677–685 (2003).
Jones, S.M. et al. Nat. Med. 11 786–790 (2005).
Sullivan, N.J. et al. Nature 424, 681–684 (2003).
Leroy, E.M. et al. Science 303, 387–390 (2004).
Formenty, P. et al. J. Infect. Dis. 179 (Suppl I), S48–S53 (1999).
Hevey, M., Negley, D., Pushko, P., Smith, J. & Schmaljohn, A. Virology 251, 28–37 (1998).
Xu, L. et al. Nat. Med 4, 37–42 (1998).
Geisbert, J. et al. Emerg. Infect. Dis. 8, 503–507 (2002).
Garbutt, M. et al. J. Virol. 78, 5458–5465 (2004).
Ramsburg, E. et al. J. Virol. 78, 3930–3940 (2004).
Ksiazek, T.G. et al. J. Infect. Dis. 179 (Suppl I), S177–S187 (1999).
Baize, S. et al. Nat. Med 5, 423–426 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baize, S. A single shot against Ebola and Marburg virus. Nat Med 11, 720–721 (2005). https://doi.org/10.1038/nm0705-720
Issue Date:
DOI: https://doi.org/10.1038/nm0705-720
This article is cited by
-
Dynamic blood single-cell immune responses in patients with COVID-19
Signal Transduction and Targeted Therapy (2021)